EUVIMEDEUVIMED entdecken
Crossref

Fertility and pregnancy outcomes in women with nonclassic 21‐hydroxylase deficiency

Camille Carrière iD, Lee S Nguyen, Carine Courtillot, Isabelle Tejedor, Zeina Chakhtoura, Christine Bellanné-Chantelot, Véronique Tardy, Monique Leban, Philippe Touraine, Anne Bachelot iD

Clinical Endocrinology · 2023-03 · 98 (3) · 315-322

DOI: 10.1111/cen.14842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 17.11.2022. Verfasst von Camille Carrière und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Reproductive Medicine and Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement,…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Abortion, Spontaneous. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Overall fertility and pregnancy outcomes in patients with nonclassic congenital adrenal hyperplasia (NCCAH) have been poorly studied. It has been suggested that hydrocortisone (HC) may decrease the time to conceive (TTC) and the rate of miscarriage in these patients.

Objectives

To describe fertility and pregnancy outcomes in a large cohort of NCCAH women. The secondary objective was to identify factors that could impact reproductive outcomes, with a particular focus on HC dose and genetic status.

Design

Retrospective study in a referral center for congenital adrenal hyperplasia. Patients and Measurements One hundred seventy‐three female patients with NCCAH confirmed by genetic testing, followed in our center between 2010 and 2019.

Results

Among the 173 patients, 95 women had a parental project, 86 of whom presented 176 pregnancies, 56% under glucocorticoid (GC) treatment and 44% without, and 76 women obtained 128 live births. Two‐thirds of the patients regularized their cycle under GC treatment, with significant decrease of androgens and progesterone levels. This treatment was associated with a shortening of TTC (coef β = −.196, information coefficient [IC] = [−10.7; −0.91], p = .021). Androgen levels and TTC were positively correlated to the rate of miscarriage (OR = 4.8, IC = [1.15; 20.34], p = .021 for testosterone, OR = 1.4, IC = [1.05; 1.81], p = .02 for androstenedione, and OR = 1.03, IC = [1.01; 1.06], p = .015 for TTC). There was no difference in terms of obstetric outcomes between patients with or without GC treatment. CYP21A2 genotype had no impact on pregnancy outcome or TTC.

Conclusions

Infertility is relative in patients with NCCAH. HC seems beneficial for fertility and pregnancy outcomes, especially for patients with menstrual disorders and high preconceptional androgen levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalAbortion, SpontaneousHumansFemalePregnancyPregnancy OutcomeRetrospective StudiesAndrogensFertilityHydrocortisoneGlucocorticoidsSteroid 21-Hydroxylase

Stichwörter der Autor:innen

21-OH deficiencyandrogencongenital adrenal hyperplasiafertilitymiscarriagepregnancyreproduction

Substanzen

AndrogensHydrocortisoneGlucocorticoidsSteroid 21-HydroxylaseCYP21A2 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Reproductive Medicine and Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, Centre de Référence des Pathologies Gynécologiques Rares, AP-HP, IE3M…
  • Clinical Investigations Center, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Research and Innovation Department, CMC Ambroise Paré, Neuilly-sur-Seine, France.
  • Department of Medical Genetics, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Sorbonne Université Médecine, Paris, France.
  • Department of Molecular Endocrinology and Rare Diseases, Center for Biology and Eastern Pathology, Civil Hospitals of Lyon, Bron, France.

ORCID-Profile: Camille Carrière, Anne Bachelot

Zitieren

APA

Carrière, C., Nguyen, L. S., Courtillot, C., Tejedor, I., Chakhtoura, Z., Bellanné-Chantelot, C., Tardy, V., Leban, M., Touraine, P., & Bachelot, A. (2023). Fertility and pregnancy outcomes in women with nonclassic 21‐hydroxylase deficiency. Clinical Endocrinology, 98(3), 315-322. https://doi.org/10.1111/cen.14842

Vancouver

Carrière C, Nguyen LS, Courtillot C, Tejedor I, Chakhtoura Z, Bellanné-Chantelot C, et al. Fertility and pregnancy outcomes in women with nonclassic 21‐hydroxylase deficiency. Clinical Endocrinology. 2023;98(3):315-322. doi:10.1111/cen.14842

BibTeX
@article{Carrire2023,
  author = {Carrière, Camille and Nguyen, Lee S and Courtillot, Carine and Tejedor, Isabelle and Chakhtoura, Zeina and Bellanné-Chantelot, Christine and Tardy, Véronique and Leban, Monique and Touraine, Philippe and Bachelot, Anne},
  title = {Fertility and pregnancy outcomes in women with nonclassic 21‐hydroxylase deficiency},
  journal = {Clinical Endocrinology},
  year = {2023},
  volume = {98},
  number = {3},
  pages = {315--322},
  doi = {10.1111/cen.14842}
}
Kostenlos starten →